SGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence

Review

Abstract: Background. Over the last few years, the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) a

Palabras claves:

Autores:

D’marco L., Morillo V., Nava M., Ortega A., Parra H., Rojas-Quintero J., Suarez M.K., Teruel J.L., Valmore Bermúdez, Villasmil N.

Fuentes:

scopus